Toi, Y. (2019) “Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study: BSA and nintedanib reduction/discontinuation”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 36(1), pp. 74–78. doi:10.36141/svdld.v36i1.7383.